One of the remarkable ways that Seeking Alpha has been able to add value for subscribers, comes from the Small Cap Insight articles being generated by many top notch contributors. There are also times when the CEO of a particular company reads our articles and decides to get personally involved.
This was just the case after I wrote this article six weeks ago, about Galena Biopharma (GALE). About a month after having that article published, I was contacted by Claire Sojda of the Life Science Group of Tiberend Strategic Advisors, Inc. giving me (Regarded Solutions), and Seeking Alpha an opportunity to an exclusive interview with the CEO of Galena, Mark Ahn, which...
Only subscribers can access this article, which is part of the PRO research library covering 3,573 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: